Search results for "arteritis"

showing 8 items of 48 documents

Tocilizumab therapy for unresponsive pulmonary arterial hypertension in a patient with Takayasu arteritis

2016

A 46-year-old female Caucasian patient was referred to our unit with upper extremity claudication, dyspnoea [New York Heart Association (NYHA) Class III], and weight loss. On physical examination, ...

medicine.medical_specialtyHypertension PulmonaryAntibodieTakayasu arteritisImmunologyPhysical examinationClass iiiTakayasu ArteritiAntibodies Monoclonal HumanizedTocilizumab therapyNew york heart association03 medical and health sciences0302 clinical medicineAntibodies Monoclonal Humanized; Female; Humans; Hypertension Pulmonary; Middle Aged; Takayasu Arteritis; Immunology and Allergy; Rheumatology; Immunology; Medicine (all)RheumatologyWeight lossInternal medicineMonoclonalmedicineImmunology and AllergyHumanized030203 arthritis & rheumatologymedicine.diagnostic_testbusiness.industryMedicine (all)General MedicinePulmonaryMiddle Agedmedicine.diseasePulmonary hypertensionSettore MED/16 - ReumatologiaHypertensionCardiologyFemalemedicine.symptomClaudicationbusiness030217 neurology & neurosurgeryHuman
researchProduct

Orthopantomography contribution to prevent isquemic stroke.

2014

Objectives: The ortopantomography (OPG) can be a valuable way for an early detection of calcified atheroma plaques, thus contributing for a preliminary stroke risk evaluation. The study looks for the existence of calcified atheroma plates through the use of OPG, comparing the results with the stenosis percentage found through eco-doppler. It has been analyzed the correlation of the number of years as a smoker, arterial hypertension and body mass index, against the risk of having calcified atheroma plaques. Study Design: Observational, transversal and prospective study with 84 patients from the Dental Center of Hospital Particular de Lisboa. First the patients answered to an inquiry and them…

medicine.medical_specialtyPathologyIsquèmia cerebralOrthopantomographyEarly detectionOdontologíaInternal medicineCarotid atheromamedicinecardiovascular diseasesProspective cohort studyGeneral DentistryStrokeArteritis de cèl·lules gegantsGiant cell arteritisCarotid diseaseOral Medicine and Pathologybusiness.industryResearchDental radiologyCerebral ischemiamedicine.disease:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludStrokeStenosisAtheromaCalcified atheromaUNESCO::CIENCIAS MÉDICASCardiologycardiovascular systemCalcified atheromabusinessRadiologia dentalBody mass indexJournal of clinical and experimental dentistry
researchProduct

Angioplastie der Arteria subclavia: Technik, Früh- und Spätergebnisse

2008

Percutaneous transluminal angioplasty (PTA) was performed in 22 patients (13 women and nine men; mean age 57 years [44-74] ) with symptomatic obstruction of the subclavian artery which was due to arteriosclerotic stenosis in 14, occlusion in six patients, radiogenic multiple stenoses in one (after radiotherapy for breast cancer), and stenoses of the left and right subclavian artery in one patient with Takayasu's arteritis. Primary success occurred in 21 (91%). The only complication was a stenosis of the brachial artery after combined brachiofemoral recanalization of a subclavian artery occlusion, but it did not require treatment. No emboli were noted. A good long-term result was achieved in…

medicine.medical_specialtyPercutaneousbusiness.industrymedicine.medical_treatmentGeneral Medicinemedicine.diseaseSurgerybody regionsStenosissurgical procedures operativemedicine.arteryAngioplastyOcclusioncardiovascular systemmedicinecardiovascular diseasesArteritisBrachial arteryComplicationbusinessSubclavian arteryDMW - Deutsche Medizinische Wochenschrift
researchProduct

Is prolonged febrile syndrome associated with reactive thrombocytosis a possible association in the diagnosis of Takayasu’s arteritis? A case report

2021

Takayasu’s arteritis is a rare, systemic, inflammatory vasculitis of large blood vessels with an unknown aetiology that more frequently affects women of childbearing age with progression to stenosis, fibrosis or thrombogenesis. Clinical manifestations are associated either with inflammation of the vascular wall (including fever, myalgia, arthralgia, weight loss) or the development of aneurysms and extensive vascular lesions, which creates challenges for a differential diagnosis. This current report presents the case of a female Caucasian patient, aged 23 years, that presented herself repetitively at the hospital reporting symptoms including fever, productive cough, myalgia associated with …

medicine.medical_specialtyfibrin monomersMedicine (General)case presentationUnknown aetiologyTakayasu's arteritisCase ReportsConstriction PathologicBiochemistryFebrile syndromeDiagnosis DifferentialR5-920Reactive thrombocytosismedicineHumansArteritisThrombocytosisThrombocytosisbusiness.industryBiochemistry (medical)Takayasu’s arteritisCell BiologyGeneral Medicinemedicine.diseaseDermatologyTakayasu Arteritisprolonged febrile syndromeChildbearing ageFemalebusinessVasculitisJournal of International Medical Research
researchProduct

Pathogenesis of polymyalgia rheumatica

2018

Polymyalgia rheumatica (PMR) is a chronic, inflammatory disorder of unknown cause, almost exclusively occurring in people aged over 50 and often associated with giant cell arteritis. The evidence that PMR occurs almost exclusively in individuals aged over 50 may indicate that age-related immune alterations in genetically predisposed subjects contribute to development of the disease. Several infectious agents have been investigated as possible triggers of PMR even though the results are inconclusive. Activation of the innate and adaptive immune systems has been proved in PMR patients as demonstrated by the activation of dendritic cells and monocytes/macrophages and the altered balance betwee…

musculoskeletal diseaseslcsh:Internal medicineGiant Cell ArteritisAdaptive immunityeducationlcsh:MedicineDiseaseT-Lymphocytes RegulatoryPathogenesisPolymyalgia rheumatica03 medical and health sciences0302 clinical medicineImmune systemRheumatologyPathogenesiHumansMedicinelcsh:RC31-1245Giant Cell ArteritiB cellAgedInnate immunity030203 arthritis & rheumatologyB-LymphocytesEvidence-Based MedicineInnate immune systembusiness.industrylcsh:RPolymyalgia rheumaticaB-LymphocyteCell DifferentiationBiomarkerPathogenesis.medicine.diseaseAcquired immune systemImmunity InnateSettore MED/16 - ReumatologiaGiant cell arteritismedicine.anatomical_structure030220 oncology & carcinogenesisImmunologyTh17 CellsbusinessBiomarkersHumanReumatismo
researchProduct

Giant cell arteritis associated with chronic active Epstein-Barr virus infection

2013

Giant cell arteritis is an inflammatory vasculopathy that preferentially affects medium-sized and large arteries. A viral cause has been suspected but not confirmed in polymyalgia rheumatica and giant-cell arteritis. We report the case of a 81-year-old female who suffered from chronic active Epstein-Barr virus infection and developed giant cell temporal arteritis.

musculoskeletal diseaseslcsh:Internal medicineSettore MED/07 - Microbiologia E Microbiologia ClinicaEpstein-Barr Virus InfectionsHerpesvirus 4 HumanBiopsyGiant Cell Arteritischronic active EBV infection (CAEBV-infection)lcsh:MedicineVirusPolymyalgia rheumaticaRheumatologyChronic Active Epstein-Barr VirusBiopsyMedicineHumansArteritislcsh:RC31-1245Aged 80 and overmedicine.diagnostic_testGiant cell arteritis (GCA) Epstein Barr virus (EBV) chronic active EBV infection (CAEBV-infection)business.industryChronic Activelcsh:Rmedicine.diseaseTemporal ArteriesGiant cell arteritisGiant cellGiant cell arteritis (GCA)ImmunologyChronic DiseaseDNA ViralFemaleGiant cell arteritis (GCA) Epstein Barr virus (EBV) chronic active EBV infection (CAEBV-infection).businessEpstein Barr virus (EBV)
researchProduct

Abatacept as Adjunctive Therapy in Refractory Polymyalgia Rheumatica.

2021

Glucocorticoids (GCs) are the mainstay of treatment for patients with polymyalgia rheumatica (PMR).1 Despite their efficacy, GCs are associated with well-known adverse events and a substantial proportion of patients with PMR do not respond adequately, or are refractory, to initial GC treatment. GC-sparing agents in PMR are limited to methotrexate (MTX).1.

musculoskeletal diseasesmedicine.medical_specialtyeducationImmunologyGiant Cell ArteritisPolymyalgia rheumaticaAbataceptDiagnosis DifferentialRheumatologyRefractoryimmune system diseasesInternal medicinemedicineImmunology and AllergyHumansskin and connective tissue diseasesAdverse effectbusiness.industryAbataceptmedicine.diseaseCombined Modality TherapyPolymyalgia RheumaticaMethotrexatebusinesshormones hormone substitutes and hormone antagonistsmedicine.drugThe Journal of rheumatology
researchProduct

Doppler ultrasound and giant cell arteritis

2010

Ana Marina Suelves1, Enrique España-Gregori1,2, Jose Tembl3, Stephanie Rohrweck1, Jose Maria Millán4, Manuel Díaz-Llopis1,4,51Service of Ophthalmology, La Fe University Hospital, Valencia, Spain; 2Department of Optics, University of Valencia, Valencia, Spain; 3Service of Neurology, La Fe University Hospital, Valencia, Spain; 4CIBERER, Ciber de Enfermedades Raras, Valencia, Spain; 5Faculty of Medicine, University of Valencia, Valencia, SpainObjective: To evaluate the utility of ultrasound in aiding the diagnosis of giant cell arteritis (GCA), in monitoring the response to corticotherapy, and in detecting early relapses.Methods: A pilot study, prospective, inc…

temporal artery biopsymedicine.medical_specialtyPathologybusiness.industrygiant cell arteritisultrasoundUltrasoundClinical OphthalmologyTemporal artery biopsymedicine.diseaseoptic nerveOphthalmologyGiant cell arteritisOphthalmologyCommentaryOptic nerveMedicineRadiologyDoppler ultrasoundskin and connective tissue diseasesbusiness
researchProduct